You are the Publication Lead at a mid-size biotech company who is working with the scientific/medical writing team of your medical communications agency. The lead author of a meta-analysis manuscript received a rejection notice from a journal that stated “…although the topic may be of interest to the readership, the Editors are concerned about the perception of bias given the statement of funding support from the sponsor and the participation of a paid, professional medical writer.” The lead author has emailed all authors, sponsor, and medical communications agency suggesting that the manuscript be revised by the authors alone so that acknowledgement of the medical writer and funding from the sponsor to support medical writing can be removed prior to resubmission to a new journal.

What Would You Do?

This poll will close on June 1, 2022.

%d bloggers like this: